{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444165382
| IUPAC_name = (''RS'')-1-[(2-Fluorophenyl)(4-fluorophenyl)benzyl]-1''H''-imidazole
| image = Flutrimazole.svg
| width = 180
| chirality = [[Racemic mixture]]

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|flutrimazole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL / P / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 119006-77-8
| ATC_prefix = D01
| ATC_suffix = AC16
| ATC_supplemental = {{ATC|G01|AF18}}
| PubChem = 3401
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3284
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 2107430
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 776S0UP252
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07193
| ChEBI_Ref = {{ebicite|changed|EBI}} 
| ChEBI = 82864

<!--Chemical data-->
| C=22 | H=16 | F=2 | N=2 
| molecular_weight = 346.373 g/mol
| smiles = Fc1ccc(cc1)C(c2c(F)cccc2)(c3ccccc3)n4ccnc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H16F2N2/c23-19-12-10-18(11-13-19)22(26-15-14-25-16-26,17-6-2-1-3-7-17)20-8-4-5-9-21(20)24/h1-16H
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = QHMWCHQXCUNUAK-UHFFFAOYSA-N
}}

'''Flutrimazole''' is a wide-spectrum [[Antifungal medication|antifungal]] drug. It is used for the topical treatment of superficial [[mycosis|mycoses]] of the [[skin]]. Flutrimazole is an [[imidazole]] derivative. Its antifungal activity has been demonstrated in ''in vivo'' and ''in vitro'' studies to be comparable to that of [[clotrimazole]] and higher than [[bifonazole]].<ref>{{cite journal|last1=Alomar|first1=A|last2=Videla|first2=S|last3=Delgadillo|first3=J|last4=Gich|first4=I|last5=Izquierdo|first5=I|last6=Forn|first6=J|title=Flutrimazole 1% Dermal Cream in the Treatment of Dermatomycoses: a Multicentre, Double-Blind, Randomized, Comparative Clinical Trial with Bifonazole 1% Cream. Efficacy of Flutrimazole 1% Dermal Cream in Dermatomycoses. Catalan Flutrimazole Study Group|journal=Dermatology (Basel, Switzerland)|date=1995|volume=190|issue=4|pages=295–300|pmid=7655109}}</ref>

==Mechanism of action==
It interferes with the synthesis of [[ergosterol]] by inhibiting the activity of the [[enzyme]] [[lanosterol 14 alpha-demethylase|lanosterol 14 α-demethylase]].

==See also==
* [[Clotrimazole]]

== References ==
The Merck Index, 12th Edition. 4247
{{reflist}}

{{Antifungals}}
{{Gynecological anti-infectives and antiseptics}}

[[Category:Fluoroarenes]]
[[Category:Imidazole antifungals]]
[[Category:Lanosterol 14α-demethylase inhibitors]]

{{antiinfective-drug-stub}}
{{genito-urinary-drug-stub}}